Mental Health in Polyendocrine Metabolic Ovarian Syndrome (PMOS): Prevalence, Aetiology and Management Across the Lifespan
Author:
Open Access
- 22 September 2026
- journal article
- Published by World Scientific Pub Co Pte Ltd in Fertility & Reproduction
- Vol. 08 (03) , 97-101
Abstract
Polyendocrine metabolic ovarian syndrome (PMOS), formerly known as polycystic ovary syndrome (PCOS), affects approximately 8%–13% of reproductive-aged women worldwide and is one of the most common endocrine disorders in women. Psychiatric comorbidities represent a substantial but often underrecognised component of this multisystem condition. This narrative review summarises current evidence on the prevalence, mechanisms and management of psychiatric disorders in PMOS across the lifespan. Women with PMOS have significantly higher rates of depression, anxiety, eating disorders, ADHD, bipolar disorder and OCD than women without PMOS. Reduced quality of life, body image distress and emerging evidence of increased suicidal ideation further contribute to the disease burden. Psychiatric morbidity persists beyond the reproductive years and appears to be amplified by obesity and metabolic dysfunction. Proposed mechanisms include hyperandrogenism, insulin resistance, neuroinflammation, hypothalamic–pituitary–adrenal axis dysregulation, sleep disturbance and psychosocial stressors. Evidence-based management includes routine screening, psychological interventions, pharmacotherapy when indicated, lifestyle modification and coordinated endocrine, metabolic and mental health care. Psychiatric comorbidity is a core clinical feature of PMOS and warrants routine screening, longitudinal surveillance and integrated management across the lifespan.Keywords
This publication has 39 references indexed in Scilit:
- Association of oral contraceptives with depression symptoms, diagnosis, and treatment in healthy women: A meta-analysisEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2026
- Women with polycystic ovary syndrome (PCOS): Likelihood of cooccurring neuropsychiatric conditions and the dual hit hypothesisFrontiers in Neuroendocrinology, 2025
- Management of polycystic ovary syndrome must include assessment and treatment of mental health symptomsFertility and Sterility, 2024
- Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary SyndromeFertility and Sterility, 2023
- Shared postulations between bipolar disorder and polycystic ovary syndrome pathologiesProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2022
- Psychiatric disorders in women with polycystic ovary syndrome: a systematic review and meta-analysisEndocrine, 2018
- Cognitive-behavioral therapy improves weight loss and quality of life in women with polycystic ovary syndrome: a pilot randomized clinical trialFertility and Sterility, 2018
- Increased odds of disordered eating in polycystic ovary syndrome: a systematic review and meta-analysisEating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity, 2018
- Role of the androgen receptor in the central nervous systemMolecular and Cellular Endocrinology, 2018
- Polycystic ovary syndrome and psychiatric disorders: Co-morbidity and heritability in a nationwide Swedish cohortPsychoneuroendocrinology, 2016